CAS: 83218-34-2 - dehydrocavidine
Fórmula:C21H18NO4
InChI:InChI=1/C21H18NO4/c1-12-14-4-5-17-21(26-11-25-17)16(14)10-22-7-6-13-8-18(23-2)19(24-3)9-15(13)20(12)22/h4-10H,11H2,1-3H3/q+1
- Sinónimos:
- 8,9-Dimethoxy-6-methyl[1,3]dioxolo[4,5-h]isoquino[2,1-b]isoquinolin-13-ium
- Benzo(a)-1,3-benzodioxolo(4,5-g)quinolizinium, 8,9-dimethoxy-6-methyl-
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Dehydrocavidine REF: 7W-GP6075CAS: 83218-34-2 | - - - | A consultar | Jue 09 May 24 |
 | Dehydrocavidine REF: TM-TN1139CAS: 83218-34-2 | 98% | A consultar | Jue 09 May 24 |
 | Dehydrocavidine REF: BP-BP1513CAS: 83218-34-2 | 95%~99% | 208,00 €~337,00 € | Lun 13 May 24 |
Ref: 7W-GP6075
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Jueves 9 de Mayo de 2024
Dehydrocavidine
CAS:83218-34-2
Dehydrocavidine (Dehydrocorydaline) has antitumor activity, it inhibits MCF-7 cell proliferation by inducing apoptosis mediated by …
Fórmula:
C21H18NO4
Pureza:
98%
Forma y color:
Solid
Peso molecular:
348.37
Ref: TM-TN1139
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 9 de Mayo de 2024
Ref: BP-BP1513
| 5mg | 208,00 € | |
| 10mg | 337,00 € |
Entrega estimada en Estados Unidos, el Lunes 13 de Mayo de 2024
